title: [Reply to "Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid"].
authors.affiliation: Servicio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza, España. Electronic address: matvigar@gmail.com.
authors.forename: Matxalen
authors.initials: M
authors.lastname: Vidal García
authors.affiliation: Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, España.
authors.forename: Sofía
authors.initials: S
authors.lastname: Samper Blasco
authors.affiliation: Servicio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza, España.
authors.forename: María Luisa
authors.initials: ML
authors.lastname: Monforte Cirac
mesh_terms: D000995:Antitubercular Agents; D007538:Isoniazid / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis; D012293:Rifampin / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin